Douglas Tsao
Stock Analyst at H.C. Wainwright
(4.92)
# 189
Out of 4,595 analysts
1230
Total ratings
55.8%
Success rate
24.3%
Average return
Main Sectors:
Stocks Rated by Douglas Tsao
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALKS Alkermes | Reiterated: Hold | $43 | $48.99 | -12.23% | 60 | Jul 29, 2026 | |
| RZLT Rezolute | Reiterated: Buy | $5 | $4.72 | +5.93% | 46 | Jul 29, 2026 | |
| OTLK Outlook Therapeutics | Rated: Hold | $0.5 → $1.6 | $0.9766 | +63.83% | 48 | Jul 28, 2026 | |
| ARGX argenx SE | Reiterated: Buy | $940 | $853.82 | +10.09% | 67 | Jul 28, 2026 | |
| NMRA Neumora Therapeutics | Reiterated: Buy | $7 | $1.61 | +334.78% | 24 | Jul 28, 2026 | |
| STO: HNSA Hansa Biopharma AB (publ) | Reiterated: Buy | kr 103.00 | kr 34.40 | +199.42% | 52 | Jul 24, 2026 | |
| TBPH Theravance Biopharma | Downgraded: Hold | $15 → $17 | $16.86 | +0.83% | 40 | Jul 7, 2026 | |
| CRNX Crinetics Pharmaceuticals | Downgraded: Hold | $81 → $85 | $83.52 | +1.77% | 64 | Jul 7, 2026 | |
| PCRX Pacira BioSciences | Reiterated: Buy | $38 | $26.41 | +43.88% | 29 | Jul 1, 2026 | |
| VRDN Viridian Therapeutics | Reiterated: Buy | $22 | $18.92 | +16.28% | 30 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.68 | - | 50 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $77.00 | - | 37 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1,201 | $307.83 | +290.15% | 55 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 | $13.50 | -25.93% | 21 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $38.62 | +3.57% | 45 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $33.91 | +0.27% | 45 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $1.22 | +883.61% | 40 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $1.41 | +396.45% | 77 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 | $3.98 | +75.88% | 43 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $117 | $136.64 | -14.37% | 78 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $26.86 | +26.58% | 18 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $74 | $62.67 | +18.08% | 16 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $5.84 | +122.60% | 56 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $40.98 | -2.39% | 10 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $1.91 | +266.49% | 13 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $125 → $5 | $0.0111 | n/a | 26 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $360 | $0.293 | n/a | 9 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $3 | $0.000001 | n/a | 13 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 | $11.90 | n/a | 4 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.03 | n/a | 19 | Nov 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €19.00 → €11.00 | €3.96 | n/a | 7 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $23 | $35.01 | n/a | 12 | Aug 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $31 → $33 | $36.33 | n/a | 2 | Jul 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $93 → $80 | $10.11 | n/a | 8 | Jun 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $9.65 | n/a | 17 | Jun 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 | $18.32 | n/a | 2 | May 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $71 → $77 | $77.29 | n/a | 6 | Feb 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $108 → $120 | $163.57 | n/a | 12 | Oct 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $120 | $235.02 | n/a | 3 | Oct 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $82.54 | n/a | 3 | Jun 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $47 → $50 | $17.56 | n/a | 6 | May 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $200 | $252.86 | n/a | 7 | Jan 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $232.51 | n/a | 5 | Nov 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $14 → $2 | $5.76 | n/a | 5 | Nov 16, 2016 |
Alkermes
Jul 29, 2026
Reiterated: Hold
Price Target: $43
Current: $48.99
Upside: -12.23%
Rezolute
Jul 29, 2026
Reiterated: Buy
Price Target: $5
Current: $4.72
Upside: +5.93%
Outlook Therapeutics
Jul 28, 2026
Rated: Hold
Price Target: $0.5 → $1.6
Current: $0.9766
Upside: +63.83%
argenx SE
Jul 28, 2026
Reiterated: Buy
Price Target: $940
Current: $853.82
Upside: +10.09%
Neumora Therapeutics
Jul 28, 2026
Reiterated: Buy
Price Target: $7
Current: $1.61
Upside: +334.78%
Hansa Biopharma AB (publ)
Jul 24, 2026
Reiterated: Buy
Price Target: kr 103.00
Current: kr 34.40
Upside: +199.42%
Theravance Biopharma
Jul 7, 2026
Downgraded: Hold
Price Target: $15 → $17
Current: $16.86
Upside: +0.83%
Crinetics Pharmaceuticals
Jul 7, 2026
Downgraded: Hold
Price Target: $81 → $85
Current: $83.52
Upside: +1.77%
Pacira BioSciences
Jul 1, 2026
Reiterated: Buy
Price Target: $38
Current: $26.41
Upside: +43.88%
Viridian Therapeutics
Jun 29, 2026
Reiterated: Buy
Price Target: $22
Current: $18.92
Upside: +16.28%
Jun 8, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.68
Upside: -
Jun 8, 2026
Reiterated: Buy
Price Target: n/a
Current: $77.00
Upside: -
Jun 8, 2026
Maintained: Buy
Price Target: $1,201
Current: $307.83
Upside: +290.15%
Jun 1, 2026
Reiterated: Hold
Price Target: $10
Current: $13.50
Upside: -25.93%
May 26, 2026
Reiterated: Buy
Price Target: $40
Current: $38.62
Upside: +3.57%
May 21, 2026
Reiterated: Buy
Price Target: $34
Current: $33.91
Upside: +0.27%
May 15, 2026
Reiterated: Buy
Price Target: $12
Current: $1.22
Upside: +883.61%
May 12, 2026
Reiterated: Buy
Price Target: $7
Current: $1.41
Upside: +396.45%
May 11, 2026
Reiterated: Hold
Price Target: $7
Current: $3.98
Upside: +75.88%
May 11, 2026
Reiterated: Buy
Price Target: $117
Current: $136.64
Upside: -14.37%
May 11, 2026
Reiterated: Buy
Price Target: $34
Current: $26.86
Upside: +26.58%
May 8, 2026
Reiterated: Buy
Price Target: $74
Current: $62.67
Upside: +18.08%
May 5, 2026
Maintained: Buy
Price Target: $13
Current: $5.84
Upside: +122.60%
Mar 11, 2026
Reiterated: Buy
Price Target: $40
Current: $40.98
Upside: -2.39%
Nov 6, 2025
Reiterated: Buy
Price Target: $7
Current: $1.91
Upside: +266.49%
Nov 14, 2024
Downgraded: Hold
Price Target: $125 → $5
Current: $0.0111
Upside: n/a
Oct 1, 2024
Reiterated: Buy
Price Target: $360
Current: $0.293
Upside: n/a
Aug 21, 2023
Reiterated: Buy
Price Target: $4 → $3
Current: $0.000001
Upside: n/a
Mar 8, 2023
Maintained: Hold
Price Target: $6
Current: $11.90
Upside: n/a
Nov 30, 2022
Rated: Hold
Price Target: n/a
Current: $2.03
Upside: n/a
Nov 1, 2022
Reiterated: Buy
Price Target: €19.00 → €11.00
Current: €3.96
Upside: n/a
Aug 6, 2018
Maintained: Hold
Price Target: $23
Current: $35.01
Upside: n/a
Jul 3, 2018
Maintained: Sell
Price Target: $31 → $33
Current: $36.33
Upside: n/a
Jun 6, 2018
Downgraded: Hold
Price Target: $93 → $80
Current: $10.11
Upside: n/a
Jun 6, 2018
Upgraded: Buy
Price Target: n/a
Current: $9.65
Upside: n/a
May 1, 2018
Initiated Coverage: Buy
Price Target: $27
Current: $18.32
Upside: n/a
Feb 16, 2018
Maintained: Hold
Price Target: $71 → $77
Current: $77.29
Upside: n/a
Oct 27, 2017
Maintained: Hold
Price Target: $108 → $120
Current: $163.57
Upside: n/a
Oct 27, 2017
Reiterated: Buy
Price Target: $100 → $120
Current: $235.02
Upside: n/a
Jun 22, 2017
Maintained: Buy
Price Target: $16
Current: $82.54
Upside: n/a
May 22, 2017
Upgraded: Buy
Price Target: $47 → $50
Current: $17.56
Upside: n/a
Jan 18, 2017
Maintained: Buy
Price Target: $200
Current: $252.86
Upside: n/a
Nov 30, 2016
Upgraded: Hold
Price Target: n/a
Current: $232.51
Upside: n/a
Nov 16, 2016
Reiterated: Sell
Price Target: $14 → $2
Current: $5.76
Upside: n/a